Esculetin and its derivatives: recent advances in efficacy, mechanisms, and translational challenges
Naunyn-Schmiedeberg's Archives of Pharmacology · 2026-06 · 399 (9) · 12813-12835
DOI: 10.1007/s00210-026-05149-4 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, online erschienen am 26.03.2026. Verfasst von Noha M Gamil und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Toxicology, College of Pharmaceutical Sciences and Drug Manufacturing, Misr University for Science and Technology (MUS…. Hauptthemen laut MEDLINE: Umbelliferones, Antioxidants. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 119 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cairo University.
Abstract (Originalsprache)
Esculetin (ESC, 6,7-dihydroxycoumarin), a naturally occurring polyphenolic coumarin found in numerous medicinal and dietary plants, has emerged as a multi-target bioactive scaffold demonstrating anti-inflammatory, antioxidant, and antiproliferative properties in diverse preclinical models. Recent investigations reveal that ESC modulates critical signaling pathways, including NF-κB, Nrf2/antioxidant response element (ARE), and mitochondrial apoptotic cascades, across multiple disease contexts encompassing dermatology, metabolic disorders, cardiovascular disease, neurodegeneration, hepatorenal protection, and malignant transformation. Structural modification of the coumarin ring system yields derivatives with enhanced target selectivity and improved metabolic stability in select compounds. However, ESC is substantially limited by poor aqueous solubility, rapid phase II metabolism, and an estimated low oral bioavailability (5–15%), representing a critical barrier to therapeutic translation. Notably, no phase II/III clinical trials have been completed, and human safety and efficacy data remain virtually absent. Recent innovations, including cocrystal technology, nanoparticle formulations, and rational structural optimization, demonstrate promise in preclinical contexts. This comprehensive review synthesizes pharmacological evidence across disease indications, evaluates bioavailability enhancement strategies, explicitly discusses evidence limitations, addresses safety considerations, and outlines translational research priorities essential for clinical or nutraceutical development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology and Toxicology, College of Pharmaceutical Sciences and Drug Manufacturing, Misr University for Science and Technology (MUST), P.O. Box 77, Giza, Egypt. noha.mohsen@must.edu.eg.
- Faculty of Pharmacy, Modern University for Information and Technology, Cairo, 11728, Egypt.
- Chemistry and Zoology Department, Faculty of Science, Menoufia University, Ashmoun, 32839, Egypt.
- Biotechnology Department, Faculty of Science, Mansoura University, Mansoura, 35516, Egypt.
- Biochemistry Department, Faculty of Science, Zagazig University, Zagazig, Egypt.
- Botany and Chemistry Department, Faculty of Science, Ain Shams University, Cairo, Egypt.
Förderung
- Cairo University
Zitieren
APA
Gamil, N. M., Essmat, R. A., Hafez, F. S., Alaziz, O. A., Bogor, A. E., Wageh, S., Youssef, D. G., Abdellatif, N., El-Shiekh, R. A., & Khalaf, S. S. (2026). Esculetin and its derivatives: recent advances in efficacy, mechanisms, and translational challenges. Naunyn-Schmiedeberg's Archives of Pharmacology, 399(9), 12813-12835. https://doi.org/10.1007/s00210-026-05149-4
Vancouver
Gamil NM, Essmat RA, Hafez FS, Alaziz OA, Bogor AE, Wageh S, et al. Esculetin and its derivatives: recent advances in efficacy, mechanisms, and translational challenges. Naunyn-Schmiedeberg's Archives of Pharmacology. 2026;399(9):12813-12835. doi:10.1007/s00210-026-05149-4
BibTeX
@article{Gamil2026,
author = {Gamil, Noha M and Essmat, Rawan Atef and Hafez, Fatma Shaban and Alaziz, Osama A and Bogor, Asmaa E and Wageh, Shehab and Youssef, Donia G and Abdellatif, Nourhan and El-Shiekh, Riham A and Khalaf, Samar S},
title = {Esculetin and its derivatives: recent advances in efficacy, mechanisms, and translational challenges},
journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
year = {2026},
volume = {399},
number = {9},
pages = {12813--12835},
doi = {10.1007/s00210-026-05149-4}
}
EUVIMED